Insider Transactions in Q1 2024 at Revance Therapeutics, Inc. (RVNC)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 18
2024
|
Dwight Moxie CLO & GC |
SELL
Open market or private sale
|
Direct |
8,125
-5.57%
|
$40,625
$5.04 P/Share
|
|
Mar 18
2024
|
Dustin S Sjuts President |
SELL
Open market or private sale
|
Direct |
9,211
-5.21%
|
$46,055
$5.04 P/Share
|
|
Mar 18
2024
|
Tobin Schilke CFO |
SELL
Open market or private sale
|
Direct |
9,361
-4.63%
|
$46,805
$5.04 P/Share
|
|
Mar 15
2024
|
Dwight Moxie CLO & GC |
SELL
Payment of exercise price or tax liability
|
Direct |
3,269
-2.19%
|
$16,345
$5.3 P/Share
|
|
Mar 15
2024
|
Dustin S Sjuts President |
SELL
Payment of exercise price or tax liability
|
Direct |
2,967
-1.65%
|
$14,835
$5.3 P/Share
|
|
Mar 15
2024
|
Mark J Foley CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
20,533
-1.01%
|
$102,665
$5.3 P/Share
|
|
Mar 15
2024
|
Tobin Schilke CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,822
-1.86%
|
$19,110
$5.3 P/Share
|
|
Mar 06
2024
|
Mark J Foley CEO |
BUY
Open market or private purchase
|
Direct |
30,000
+2.87%
|
$180,000
$6.98 P/Share
|
|
Feb 29
2024
|
Dustin S Sjuts President |
BUY
Grant, award, or other acquisition
|
Direct |
22,110
+10.95%
|
-
|
|
Feb 29
2024
|
Dwight Moxie CLO & GC |
BUY
Grant, award, or other acquisition
|
Direct |
15,143
+9.21%
|
-
|
|
Feb 29
2024
|
Tobin Schilke CFO |
BUY
Grant, award, or other acquisition
|
Direct |
17,447
+7.81%
|
-
|
|
Feb 29
2024
|
Mark J Foley CEO |
BUY
Grant, award, or other acquisition
|
Direct |
70,750
+6.7%
|
-
|
|
Jan 31
2024
|
Tobin Schilke CFO |
BUY
Grant, award, or other acquisition
|
Direct |
96,667
+33.91%
|
-
|
|
Jan 31
2024
|
Dwight Moxie CLO & GC |
BUY
Grant, award, or other acquisition
|
Direct |
90,000
+40.17%
|
-
|